U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma von HERNDON, Thomas M, DEISSEROTH, Albert, PALMBY, Todd R, JEE, Josephine, ADAMS, William, MAHAYNI, Houda, BROWN, Janice, DORANTES, Angelica, SRIDHARA, Rajeshwari, FARRELL, Ann T, PAZDUR, Richard, KAMINSKAS, Edvardas, KANE, Robert C, KOTI, Kallappa M, ROTHMANN, Mark D, HABTEMARIAM, Bahru, BULLOCK, Julie, BRAY, Jeffrey D, HAWES, Jessica

Volltext

U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma von DE CLARO, R. Angelo, MCGINN, Karen, ROTHMANN, Mark, SHAPIRO, Marjorie, BORREGO, Francisco, CLOUSE, Kathleen, XIAO HONG CHEN, BROWN, Janice, AKINSANYA, Lara, KANE, Robert, KAMINSKAS, Edvardas, FARRELL, Ann, KWITKOWSKI, Virginia, PAZDUR, Richard, BULLOCK, Julie, KHANDELWAL, Aakanksha, HABTEMARIAM, Bahru, OUYANG, Yanli, SABER, Haleh, LEE, Kyung, KOTI, Kallappa

Volltext

U.S. Food and Drug Administration Approval: Panitumumab for Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Carcinoma with Progression Following Fluoropyrimidine-... von GIUSTI, Ruthann M, SHASTRI, Kaushikkumar, KEEGAN, Patricia, WEISS, Karen D, PAZDUR, Richard, PILARO, Anne M, FUCHS, Chana, CORDOBA-RODRIGUEZ, Ruth, KOTI, Kallappa, ROTHMANN, Mark, MEN, Angela Yuxin, HONG ZHAO, HUGHES, Monica

Volltext

New Tests for Assessing Non-Inferiority and Equivalence from Survival Data von Koti, Kallappa M.

Volltext

Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker von Koti, Kallappa M.

Volltext

Use of the Fieller-Hinkley Distribution of the Ratio of Random Variables in Testing for Noninferiority von Koti, Kallappa M.

Volltext

New Tests for Null Hypothesis of Non Unity Ratio of Proportions von Koti, Kallappa M.

Volltext

Failure-Time Mixture Models: Yet Another Way to Establish Efficacy von Koti, Kallappa M.

Volltext

On a Primary Efficacy Endpoint von Koti, Kallappa M.

Volltext

Evaluating and Adjusting for Premature Censoring of Progression-Free Survival von Rothmann, Mark, Koti, Kallappa, Lee, Kyung Yul, Lu, Hong Laura, Shen, Yuan Li, Zhang, Jenny J., Jin, Mei, Zhou, Haojin

Volltext

Missing Data in Biologic Oncology Products von Rothmann, Mark D., Koti, Kallappa, Lee, Kyung Yul, Lu, Hong Laura, Shen, Yuan Li

Volltext

Gamma failure-time mixture models: yet another way to establish efficacy von Koti, Kallappa M.

Volltext

Sign test for ranked-set sampling von Koti, Kallapa M., Jogesh Babu, Gutti

Volltext

Minimax policies for a two-location/ two-product inventory system von Koti, Kallappa M.

Volltext

A note on sum-quota sampling von Koti, Kallappa M.

Volltext

Some inequalities in elementary special functions with applications to nonparametric statistical inference von Koti, Kallappa M.

Volltext

Some inequalities in incomplete beta functions by using statistical techniques von Koti, Kallappa M.

Volltext

Optimum stratified sampling using prior information von Koti, Kallappa M

Volltext bestellen